TickerFacts.

YD Bio Ltd (YDES): EPS (Diluted)

Annual figures by period end, from SEC filings.

-$0.12
Year ended 2025-12-31
2023-12-31: $0.002024-12-31: -$0.022025-12-31: -$0.12-$0.12
2023-12-31 EPS (Diluted) (USD per share) 2025-12-31
Period endedEPS (Diluted)Change YoYSource filing
2025-12-31-$0.12n/m2026-04-30, From 2025-01-01
2024-12-31-$0.02n/a2026-04-30, From 2024-01-01
2023-12-31$0.00n/a2026-04-30, From 2023-01-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
YD Bio Ltd (YDES)2025-12-31-$0.12n/m
Sera Prognostics, Inc. (SERA)2025-12-31-$0.67n/m
Aclarion, Inc. (ACON)2025-12-31-$13.61n/m
BioNexus Gene Lab Corp (BGLC)2024-12-31-$0.09n/m
American Shared Hospital Services (AMS)2025-12-31-$0.23n/m
CapForce Inc. (CFOR)2025-12-31$2.32+0.9%
Exagen Inc. (XGN)2025-12-31-$0.93n/m
Personalis, Inc. (PSNL)2025-12-31-$0.91n/m
Biodesix Inc (BDSX)2025-12-31-$4.67n/m

Compare YDES, SERA, ACON, BGLC side by side · Screen every company in Services-Medical Laboratories ↗